Meridian Bioscience/ US5895841014 /
| 2023-01-30 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 33.98USD | - | 112,605 Turnover: 3.83 mill. |
-Bid Size: - | -Ask Size: - | 1.5 bill.USD | - | 35.02 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.97 USD | -41.21% |
| EPS Diluted: | 0.96 USD | -40.74% |
| Revenues per Share: | 7.60 USD | 3.65% |
| Book Value per Share: | 8.40 USD | 10.93% |
| Cash Flow per Share: | 1.88 USD | 21.87% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 333.02 USD | 4.76% |
| Net Income: | 42.46 USD | -40.54% |
| Operating Cash Flow: | 82.36 USD | - |
| Cash and Cash Equivalents: | 81.45 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 35.02 | 32.51 |
| P/S Ratio: | 4.47 | 4.15 |
| P/BV ratio: | 4.05 | 3.75 |
| P/CF Ratio: | 18.08 | 16.78 |
| PEG: | -0.85 | -0.79 |
| Earnings Yield: | 2.86% | 3.08% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 1.5 bill. USD | 1.38 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 44.04 mill. | |
Profitability
| Gross Profit Margin: | 56.56% |
| EBIT Margin: | 16.33% |
| Net Profit Margin: | 12.75% |
| Return on Equity: | 11.54% |
| Return on Assets: | 9.17% |
Financial Strength
| Liquidity I / Cash Ratio: | 140.56% |
| Liquidity II / Quick Ratio: | 222.06% |
| Liquidity III / Current Ratio: | 363.41% |
| Debt / Equity Ratio: | 25.82% |
| Dynam. Debt / Equity Ratio: | 115.39% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2022-09-30 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
